In the News / Politics

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

Increased Costs of Treatment due to the DSM-V: Implications for Pharmacy Practice

By: James W. Schurr and David Gao, PharmD Candidates 2014 - A recent Op-ed in Newsday by Allen Frances, MD…

13 years ago

U.S. v Caronia: Misdemeanor or Constitutional Right?

By: Tamara Yunusova, Staff Editor - On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first…

13 years ago

Extending the Standing Order for Tdap

By:  Christina Tarantola, PharmD, PGY-1 Resident at Kings Pharmacy - The New York State Department of Health issued a health…

13 years ago

College of Pharmacy and Health Sciences Collaborates

By:  Tasnima Nabi, Associate Student Editor - St. John’s University College of Pharmacy and Health Sciences has collaborated with the…

13 years ago

A Look at Primary Medication NonAdherence and How it can be Overcome

By:  Erica Dimitropoulos, Assistant Student Editor - Although clinical trials can affirm the efficacy and advantages of all marketed medications,…

13 years ago

Varizig® for Chickenpox Symptoms

By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012.…

13 years ago

The Opioid Debate: PROP and PROMPT Battle Away

By: Tamara Yunusova - On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing…

13 years ago

New Healthcare Law Concerning Birth Control Causes Debate

By: Katie Cimmino, Pharm D. Candidate c/o 2015 -  With the start of the New Year the French government is…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago